Absence of cochleotoxicity measured by standard and high-frequency pure tone audiometry in a trial of once- versus three-times-daily tobramycin in cystic fibrosis patients.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples